Explainable Machine Learning for the Assessment of Donor Grafts in Liver Transplantation
1 other identifier
observational
5,636
1 country
1
Brief Summary
Clinically, organ evaluation generally performed by the senior surgeons based on their experience and the visual and tactual inspection of the graft during procurement. However, it is proved that transplant surgeons intuition in the evaluation of donor risk and the estimation of steatosis is inconsistent and usually inaccurate. Besides, graft assessment is a dynamic process refer to amount of complex factors, which is considered to be an incredibly complicated relationship that is nonlinear in nature. Unfortunately, the classical statistic techniques in vogue such as multiple regression require the statistical assumption of independent and linear relationships between explanatory and outcome variables, and fail to analyse a large number of variables. We attempted to develop liver graft assessment models by predicting postoperative DGF using several ML techniques. Secondly, the best prediction model was selected by comparing the performance of different AI algorithms and logistic regression. Finally, we sought to explain the decision made by AI algorithms using a visualization algorithm based on the best prediction model, helping clinicians evaluate specific organ and whether to receive that may develop DGF postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 28, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedAugust 2, 2024
July 1, 2024
6.5 years
July 28, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Delayed Graft Function (DGF)
defined as early graft dysfunction without the need for a second liver transplant or death
Within 7 days after liver transplantation
Study Arms (2)
DGF
patients occured delayed graft function after liver transplantation
non-DGF
patients NOT occured delayed graft function after liver transplantation
Interventions
Eligibility Criteria
Adult patients who underwent deceased donor liver transplantation
You may qualify if:
- Age≥18 years-old
- Underwent deceased donor liver transplantation
You may not qualify if:
- Underwent living-donor LT;
- Missing rates of data were more than 80%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
July 28, 2024
First Posted
August 2, 2024
Study Start
January 1, 2017
Primary Completion
June 30, 2023
Study Completion
June 30, 2024
Last Updated
August 2, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share